Dr. McGill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-3500Fax+1 314-230-1119
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
- Beaumont Hospital, Royal OakFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1985
- Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 1980 - 1984
- Michigan State University College of Human MedicineClass of 1979
Certifications & Licensure
- MO State Medical License 1985 - 2025
- MI State Medical License 1981 - 2003
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Outstanding Physician Clinician in Diabetes American Diabetes Association, 2022
- America's Top Doctors Castle Connolly, 2007-2022
- Excellence in Teaching Washington University, 2020
- Join now to see all
Clinical Trials
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
- A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes Start of enrollment: 2014 Feb 01
- Metabolic Effects of Hydroxychloroquine Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 424 citationsRole of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind studyPriscilla Hollander, Steven C. Elbein, Irl B. Hirsch, David E. Kelley, Janet B. McGill
Diabetes Care. 1998-08-01 - 165 citationsAACE/ACE comprehensive diabetes management algorithm 2015.Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden
Endocrine Practice. 2015-05-01 - 76 citationsComparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Usi...Yan Xie, Benjamin Bowe, Andrew K. Gibson, Janet B. McGill, Geetha Maddukuri
Diabetes Care. 2020-09-16
Journal Articles
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesAnuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
- Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune DiseaseKavita Juneja, Janet B McGill, Jing W Hughes, Garry S Tobin, C Rachel Kilpatrick, Diabetes Care
Lectures
- New Strategies for Obesity Management: Risk Stratification & Long-term Weight ControlAmerican Association of Clinical Endocrinologists (AACE), Novi, Michigan - 10/11/2013
- New Strategies for Obesity Management: Risk Stratification & Long-term Weight ControlAmerican Association of Clinical Endocrinologists (AACE), Novi, Michigan - 10/11/2013
- Hot Topics in Internal Medicine - CME Getaways Las VegasCME Getaways, Las Vegas, Nevada - 9/28/2012
Authored Content
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020
Press Mentions
- Finerenone plus SGLT2 Inhibition May Yield Additive CV, Kidney Benefits: FIGARO-DKDOctober 5th, 2021
- Clinical Highlights: 15th Annual CMHC Live OnlineOctober 29th, 2020
- YOUR HEALTH: Can Type 2 Medicines Help Type 1 Diabetics?September 27th, 2019
- Join now to see all
Grant Support
- Diabetes Research And Training CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- The Dream StudyNational Center For Research Resources2004–2007
- Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d)National Center For Research Resources2005
- Early Diabetes Intervention Program (EDIP)National Center For Research Resources1999–2005
- Early Diabetes Intervention Program. (EDIP)National Center For Research Resources2004
- Correlation Of 15ag To Established Glycemia Markers In DiabetesNational Center For Research Resources2004
- Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d).National Center For Research Resources2004
- Plant Sterols In Cholesterol AbsorptionNational Center For Research Resources2000–2002
- Nabumetone, Celcoxib &Ibuprofen On Blood Pressure Control In HypertensionNational Center For Research Resources2000–2002
- Inhaled Vs. Subcutaneous Human Insulin Therapy In Type 2 DiabetesNational Center For Research Resources2000–2002
- Inhaled Human Insulin Therapy In Type 2 DiabetesNational Center For Research Resources2000–2002
- Gi262570 Sodium Tablets W/ Metformin For 26 WKS In NIDDMNational Center For Research Resources2000–2002
- Gi262570 Sodium Tablets Monotherapy For 26wks In NIDDMNational Center For Research Resources2000–2002
- External Continuous Subcutaneous Insulin Aspart Infusion In NIDDMNational Center For Research Resources2000–2002
- External Continuous Infusion Of Insulin Aspart, Lispro &Buffered Regular In IDDMNational Center For Research Resources2000–2002
- Evaluation Of Multi Dose Regimen L-753,037 In African Americans With HypertensionNational Center For Research Resources2000–2002
- Evaluate 3 Fixed Doses Of SDZ Djn 608 In NIDDMNational Center For Research Resources2000–2002
- Effect Of A-100 On Glycemic Control In Overweight NIDDM Treated With MetforminNational Center For Research Resources2000–2002
- Diabetes Center--Clinical Research Facility, Research, And TrainingNational Center For Research Resources2000–2002
- Comparison Of Tcpi Td-Glucose With Finger Stick MethodsNational Center For Research Resources2000–2002
- SDZ Djn 608 Monotherapy Compared To Glibenclamide Monotherapy B304 ENational Center For Research Resources1999–2002
- Repaglinide And Troglitazone In Treatment Of Type II Diabetes MellitusNational Center For Research Resources1999–2002
- Oral Gi262570x Monotherapy 12weeks Duration Subjects With Type2 DiabetesNational Center For Research Resources1999–2002
- Metformin And Glyburide Combination Products In Diabetes PatientsNational Center For Research Resources1999–2002
- Brl49653c Combination With Glyburide To Patients With DiabetesNational Center For Research Resources1999–2002
- Brl49653 Combination With Insulin To Patients With Noninsulin Dependent DiabetesNational Center For Research Resources1999–2002
- Antiproteinuric Effects Of Omapatrilat And Amlodipine In Type II DiabetesNational Center For Research Resources1999–2002
- 52 Week, Orlistat Treatment In Obese Patients With Type 2 Diabetes MellitusNational Center For Research Resources1999–2002
- Oral Zopolrestat In Subjects With Peripheral Symmetrical Diabetic PolyneuropathyNational Center For Research Resources1998–2002
- 26 Weeks Of BRL 49653c Given 2X Day To Patients W/ NIDDM &Inadequate ControlNational Center For Research Resources1998–2002
- Renal Protective Effects Of Losartan In Patients With NIDDM And NephropathyNational Center For Research Resources1997–2002
- OPEN Label Long Term Tolerability Of Pioglitazone AD 48333 In NIDDM PatientsNational Center For Research Resources1997–2002
- Oral Zololrestat In Normotensive, Type I Diabetics With Incipient NephropathyNational Center For Research Resources1996–2002
- Diabetes Registry--Research And Education FacilityNational Center For Research Resources1996–2002
- Oral Gi26257ox In Patients W Type II Diabetes MellitusNational Center For Research Resources1999
- Randomized Study To Determine Effects Of Subcutaneous Recombinant LeptinNational Center For Research Resources1998–1999
- PET Detection Of The Diabetic HeartNational Center For Research Resources1998–1999
- Intra And Intersubject Variability In Absorption Of Subcutaneous InsulinNational Center For Research Resources1998–1999
- Human Insulin Analogue X14 &Regular Human Insulin As Meal Related InsulinNational Center For Research Resources1998–1999
- Evaluation Of Dose Ranges Of SC 6610 In Treatment Of HypertensionNational Center For Research Resources1998–1999
- Evaluate Safety, Efficacy And Tolerability Of 3 Fixed Doses Of SDZ Djn 608National Center For Research Resources1998–1999
- Effects Of Subcutaneous Admin Of Insulin &Rhigf 1 In Subjects With IDDMNational Center For Research Resources1998–1999
- BRL 49653c Admin 1X Day To PTS W/ NIDDM Inadequately Controlled On GlyburideNational Center For Research Resources1998–1999
- 28 Week OPEN Clinical Trial Comparing HOE 901 Insulin With NPH Human InsulinNational Center For Research Resources1998–1999
- 16 Week Multicenter Clinical Trial Comparing H0e901 W/ NPH Human InsulinNational Center For Research Resources1998–1999
- Venlafaxine ER Capsules For Chronic Pain Associated With Diabetic NeuropathyNational Center For Research Resources1997–1999
- Tolerability Of Pramlintide In Patients With Type I DiabetesNational Center For Research Resources1997–1999
- Telmisartan As Monotherapy Or In Combination With Other Antihypertensive DrugsNational Center For Research Resources1997–1999
- Sucralose Versus Placebo On Glucose Homeostasis In NIDDM SubjectsNational Center For Research Resources1997–1999
- Oral Ana756 In Treatment Of Patients With Essential HypertensionNational Center For Research Resources1997–1999
- Pimagedine In Patients With Type II Diabetes Mellitus And Diabetic NephropathyNational Center For Research Resources1996–1999
- Efect Of Ac137 On Plasma Glucose Profiles In Patients With Type II DiabetesNational Center For Research Resources1996–1999
- Aminoguanidine In Diabetic Patients With Overt Diabetic NephropathyNational Center For Research Resources1996–1999
- Two Formulations Of HOE 901 Insulin In Comparison To NPH Insulin In NIDDMNational Center For Research Resources1997
- Telmisartan And Hctz In Patients With Mild To Moderate Essential HypertensionNational Center For Research Resources1997
- Oral Zopolrestat In Subjects With Peripheral Symmetical Diabetic PolyneuropathyNational Center For Research Resources1997
- Orlistat In The Treatment Of Obese Subjects With NIDDMNational Center For Research Resources1996–1997
- Miglitol As Compared To A Fixed Dose Of Sulfonylurea In The Treatment Of NIDDMNational Center For Research Resources1996–1997
- Metformin Hydrochloride In Patients With Noninsulin Dependent Diabetes MellitusNational Center For Research Resources1996–1997
- Ci-991 In NIDDM To Assess Potential Effects On Cardiac Mass And FunctionNational Center For Research Resources1996–1997
- Angiotensin Converting Enzyme Inhibition In Diabetic NephropathyNational Center For Research Resources1996–1997
- U-98079a (DAV6215CL) Capsules In The Treatment Of Mixed Anxiety And DepressionNational Center For Research Resources1996
- Triproamylin On Glucose Profile And Pharmacokinetics In Juvenile Onset DiabetesNational Center For Research Resources1996
- Oral Dose Levels Of Rs-15385-197 In Men With Erectile DisorderNational Center For Research Resources1996
- Occlusions Of Insulin Delivery In Continuous Subcutaneous Insulin Infusion (HumanNational Center For Research Resources1990
- Multicenter Clinical Trial Converting Enzyme Inhibition In Diabetic NephropathyNational Center For Research Resources1990
- Energy Metabolism During AnesthesiaNational Center For Research Resources1990
- Effect Of Captopril On Microalbuminia/Insulin Dependent Diabetes MellitusNational Center For Research Resources1990
Committees
- member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2033
- member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
- member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
- member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
- member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
Professional Memberships
- Member
- Endocrine SocietyMember
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: